Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem

Walter Ageno: research support from Bayer and advisory boards for Astra Zeneca, Bayer, BMS-Pfizer, Norgine, Sanofi, Techdow, Viatris. Davide Santagata: nothing to disclose. Marco Paolo Donadini: nothing to disclose.